{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:34:31Z","timestamp":1789648471144,"version":"4.0.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T00:00:00Z","timestamp":1283472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00404-010-1646-3","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T04:47:55Z","timestamp":1283402875000},"page":"7-18","source":"Crossref","is-referenced-by-count":68,"title":["Antibiotic chemotherapy during pregnancy and lactation period: aspects for consideration"],"prefix":"10.1007","volume":"283","author":[{"given":"Ioannis","family":"Mylonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,3]]},"reference":[{"key":"1646_CR1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00129-005-1734-9","volume":"38","author":"I Mylonas","year":"2005","unstructured":"Mylonas I, Dian D, Friese K (2005) Antibiotikatherapie in der Schwangerschaft. Gynakologe 38:761\u2013770","journal-title":"Gynakologe"},{"key":"1646_CR2","doi-asserted-by":"crossref","unstructured":"Mylonas I, Friese K (2009) Infektionen in der Gyn\u00e4kologien und Geburtshilfe. Elsevier Verlag\/Urban & Fischer, M\u00fcnchen","DOI":"10.1007\/978-3-540-78375-6_9"},{"key":"1646_CR3","volume-title":"Infektionen in der Gyn\u00e4kologie und Geburtshilfe","author":"K Friese","year":"2002","unstructured":"Friese K, Sch\u00e4fer A, Hof H (2002) Infektionen in der Gyn\u00e4kologie und Geburtshilfe. Springer, Berlin"},{"key":"1646_CR4","unstructured":"Friese K, M\u00f6rike K, Neumann G, Windorfer A (2009) Arzneimittel in der Schwangerschaft und Stillzeit: Ein Leitfaden f\u00fcr \u00c4rzte und Apotheker Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart"},{"key":"1646_CR5","volume-title":"Arzneimitteltherapie in der Frauenheilkunde","author":"K Friese","year":"2002","unstructured":"Friese K, Melchert F (2002) Arzneimitteltherapie in der Frauenheilkunde. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart"},{"key":"1646_CR6","volume-title":"Drugs in pregnancy and lactation","author":"GG Briggs","year":"1998","unstructured":"Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in pregnancy and lactation. Williams & Wilkins, Baltimore"},{"key":"1646_CR7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/07399339009515912","volume":"11","author":"EJ Saunders","year":"1990","unstructured":"Saunders EJ, Saunders JA (1990) Drug therapy in pregnancy: the lessons of diethylstilbestrol, thalidomide, and bendectin. Health Care Women Int 11:423\u2013432","journal-title":"Health Care Women Int"},{"key":"1646_CR8","unstructured":"(2001) Erythromycin-induced pyloric stenosis in infants. Prescrire Int 10:16"},{"key":"1646_CR9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1067\/mpd.2001.117577","volume":"139","author":"BE Mahon","year":"2001","unstructured":"Mahon BE, Rosenman MB, Kleiman MB (2001) Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 139:380\u2013384","journal-title":"J Pediatr"},{"key":"1646_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1600-0463.2003.11101031.x-i1","volume":"116","author":"M Norgaard","year":"2008","unstructured":"Norgaard M, Skriver MV, Sorensen HT, Schonheyder HC, Pedersen L (2008) Risk of miscarriage for pregnant users of pivmecillinam: a population-based case\u2013control study. APMIS 116:278\u2013283","journal-title":"APMIS"},{"key":"1646_CR11","first-page":"483","volume":"60","author":"F Sa del Fiol","year":"2005","unstructured":"Sa del Fiol F, Gerenutti M, Groppo FC (2005) Antibiotics and pregnancy. Pharmazie 60:483\u2013493","journal-title":"Pharmazie"},{"key":"1646_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pds.1225","volume":"15","author":"U Amann","year":"2006","unstructured":"Amann U, Egen-Lappe V, Strunz-Lehner C, Hasford J (2006) Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf 15:327\u2013337","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1646_CR13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1055\/s-2006-939888","volume":"131","author":"T Bertsche","year":"2006","unstructured":"Bertsche T, Haas M, Oberwittler H, Haefeli WE, Walter-Sack I (2006) Drugs during pregnancy and breastfeeding: new risk categories\u2014antibiotics as a model. Dtsch Med Wochenschr 131:1016\u20131022","journal-title":"Dtsch Med Wochenschr"},{"key":"1646_CR14","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/01.AOG.0000216197.26783.b5","volume":"107","author":"GG Nahum","year":"2006","unstructured":"Nahum GG, Uhl K, Kennedy DL (2006) Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 107:1120\u20131138","journal-title":"Obstet Gynecol"},{"key":"1646_CR15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-2008-1046742","volume":"133","author":"A Haas","year":"2008","unstructured":"Haas A, Maschmeyer G (2008) Antibiotic therapy in pregnancy. Dtsch Med Wochenschr 133:511\u2013515","journal-title":"Dtsch Med Wochenschr"},{"key":"1646_CR16","volume-title":"Arzneimittelverordnung in Schwangerschaft und Stillzeit","author":"C Sch\u00e4fer","year":"2001","unstructured":"Sch\u00e4fer C, Spielman H (2001) Arzneimittelverordnung in Schwangerschaft und Stillzeit. Elsevier Urban und Fischer, Berlin, Jena"},{"key":"1646_CR17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1469-0691.2002.00368.x","volume":"8","author":"BB Dencker","year":"2002","unstructured":"Dencker BB, Larsen H, Jensen ES, Schonheyder HC, Nielsen GL, Sorensen HT (2002) Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero. Clin Microbiol Infect 8:196\u2013201","journal-title":"Clin Microbiol Infect"},{"key":"1646_CR18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1067\/mob.2003.382","volume":"188","author":"DF Lewis","year":"2003","unstructured":"Lewis DF, Adair CD, Robichaux AG, Jaekle RK, Moore JA, Evans AT, Fontenot MT (2003) Antibiotic therapy in preterm premature rupture of membranes: are seven days necessary? A preliminary, randomized clinical trial. Am J Obstet Gynecol 188:1413\u20131416 (discussion 1416\u20131417)","journal-title":"Am J Obstet Gynecol"},{"key":"1646_CR19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0301-2115(00)00545-5","volume":"97","author":"AE Czeizel","year":"2001","unstructured":"Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case\u2013control teratologic study. Eur J Obstet Gynecol Reprod Biol 97:188\u2013192","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1646_CR20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ajhp\/57.3.215","volume":"57","author":"TR Sigg","year":"2000","unstructured":"Sigg TR, Kuhn BR (2000) Inadvertent intrauterine infusion of ampicillin\u2013sulbactam. Am J Health Syst Pharm 57:215","journal-title":"Am J Health Syst Pharm"},{"key":"1646_CR21","volume-title":"Antibiotika\u2014Therapie in Klinik und Praxis","author":"C Simon","year":"2000","unstructured":"Simon C, Stille W (2000) Antibiotika\u2014Therapie in Klinik und Praxis. Schattauer, Stuttgart"},{"key":"1646_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9378(99)70443-6","volume":"181","author":"G Garratty","year":"1999","unstructured":"Garratty G, Leger RM, Arndt PA (1999) Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures. Am J Obstet Gynecol 181:103\u2013104","journal-title":"Am J Obstet Gynecol"},{"key":"1646_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2125.2000.00240.x","volume":"50","author":"M Berkovitch","year":"2000","unstructured":"Berkovitch M, Segal-Socher I, Greenberg R, Bulkowshtein M, Arnon J, Merlob P, Or-Noy A (2000) First trimester exposure to cefuroxime: a prospective cohort study. Br J Clin Pharmacol 50:161\u2013165","journal-title":"Br J Clin Pharmacol"},{"key":"1646_CR24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1067\/mob.2001.113905","volume":"184","author":"AE Czeizel","year":"2001","unstructured":"Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based, case\u2013control study. Am J Obstet Gynecol 184:1289\u20131296","journal-title":"Am J Obstet Gynecol"},{"key":"1646_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002018-200022010-00007","volume":"22","author":"W Manka","year":"2000","unstructured":"Manka W, Solowiow R, Okrzeja D (2000) Assessment of infant development during an 18-month follow-up after treatment of infections in pregnant women with cefuroxime axetil. Drug Saf 22:83\u201388","journal-title":"Drug Saf"},{"key":"1646_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-199427010-00005","volume":"27","author":"A Heikkila","year":"1994","unstructured":"Heikkila A, Erkkola R (1994) Review of \u03b2-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules. Clin Pharmacokinet 27:49\u201362","journal-title":"Clin Pharmacokinet"},{"key":"1646_CR27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0890-6238(99)00046-5","volume":"13","author":"AE Czeizel","year":"1999","unstructured":"Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (1999) A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 13:531\u2013536","journal-title":"Reprod Toxicol"},{"key":"1646_CR28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2007-994053","volume":"15","author":"A Einarson","year":"1998","unstructured":"Einarson A, Phillips E, Mawji F, D\u2019Alimonte D, Schick B, Addis A, Mastroiacova P, Mazzone T, Matsui D, Koren G (1998) A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Perinatol 15:523\u2013525","journal-title":"Am J Perinatol"},{"key":"1646_CR29","first-page":"162","volume":"10","author":"B Schick","year":"1996","unstructured":"Schick B, Hom M, Librizzi R, Donnenfeld A (1996) Pregnancy outcome following exposure to clarithromycin. Reprod Toxicol 10:162","journal-title":"Reprod Toxicol"},{"key":"1646_CR30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/j.1600-0412.2000.079003234.x","volume":"79","author":"AE Czeizel","year":"2000","unstructured":"Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT (2000) A case\u2013control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand 79:234\u2013237","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1646_CR31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","volume":"20","author":"BA Kallen","year":"2005","unstructured":"Kallen BA, Otterblad Olausson P, Danielsson BR (2005) Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20:209\u2013214","journal-title":"Reprod Toxicol"},{"key":"1646_CR32","doi-asserted-by":"crossref","DOI":"10.3109\/9780203909904","volume-title":"Chemically induced birth defects","author":"JL Schardein","year":"2000","unstructured":"Schardein JL (2000) Chemically induced birth defects. Marcel Dekker, New York"},{"key":"1646_CR33","first-page":"883","volume":"3","author":"JH Lewis","year":"1991","unstructured":"Lewis JH (1991) Drug hepatotoxicity in pregnancy. Eur J Gastroenterol Hepatol 3:883\u2013891","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1646_CR34","first-page":"2113","volume":"92","author":"MF Trexler","year":"1997","unstructured":"Trexler MF, Fraser TG, Jones MP (1997) Fulminant pseudomembranous colitis caused clindamycin phosphate vaginal cream. Am J Gastroenterol 92:2113","journal-title":"Am J Gastroenterol"},{"key":"1646_CR35","unstructured":"Joesoef M, Schmid G (2002) Bacterial vaginosis. Clin Evid 1592\u20131600"},{"key":"1646_CR36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00365540050165974","volume":"32","author":"AE Czeizel","year":"2000","unstructured":"Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT (2000) A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis 32:309\u2013313","journal-title":"Scand J Infect Dis"},{"key":"1646_CR37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00003495-199754050-00003","volume":"54","author":"CD Freeman","year":"1997","unstructured":"Freeman CD, Klutman NE, Lamp KC (1997) Metronidazole: a therapeutic review and update. Drugs 54:679\u2013708","journal-title":"Drugs"},{"key":"1646_CR38","first-page":"440","volume":"61","author":"O Diav-Citrin","year":"2000","unstructured":"Diav-Citrin O, Gotteiner T, Shechtman S, Arnon J, Ornoy A (2000) Pregnancy outcome following gestational exposure to metronidazole: a prospective controlled cohort study (abstract). Teratology 61:440","journal-title":"Teratology"},{"key":"1646_CR39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1461::AID-CNCR25>3.0.CO;2-1","volume":"83","author":"PB Thapa","year":"1998","unstructured":"Thapa PB, Whitlock JA, Brockman Worrell KG, Gideon P, Mitchel EF, Roberson P, Pais R, Ray WA (1998) Prenatal exposure to metronidazole and risk of childhood cancer. Cancer 83:1461\u20131468","journal-title":"Cancer"},{"key":"1646_CR40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0025-6196(12)64947-7","volume":"63","author":"CM Beard","year":"1988","unstructured":"Beard CM, Noller KL, O\u2019Fallon WM, Kurland LT, Dahlin DC (1988) Cancer after exposure to metronidazole. Mayo Clin Proc 63:147\u2013153","journal-title":"Mayo Clin Proc"},{"key":"1646_CR41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2125.1997.00660.x","volume":"44","author":"T Caro-Paton","year":"1997","unstructured":"Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvares-Requejo A, Rodriguez-Pinilla E (1997) Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol 44:179\u2013182","journal-title":"Br J Clin Pharmacol"},{"key":"1646_CR42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1471-0528.1998.tb10094.x","volume":"105","author":"AE Czeizel","year":"1998","unstructured":"Czeizel AE, Rockenbauer M (1998) A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 105:2\u20137","journal-title":"Br J Obstet Gynaecol"},{"key":"1646_CR43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0890-6238(90)90042-T","volume":"4","author":"AE Czeizel","year":"1990","unstructured":"Czeizel AE (1990) A case\u2013control analysis of the teratogenic effects of co-trimoxazole. Reprod Toxicol 4:305\u2013313","journal-title":"Reprod Toxicol"},{"key":"1646_CR44","volume-title":"Birth defects and drugs in pregnancy","author":"OP Heinonen","year":"1977","unstructured":"Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton"},{"key":"1646_CR45","first-page":"115","volume":"201","author":"K Friese","year":"1997","unstructured":"Friese K, Hlobil H (1997) Prenatal toxoplasmosis: is screening in pregnancy necessary? Z Geburtshilfe Neonatol 201:115\u2013120","journal-title":"Z Geburtshilfe Neonatol"},{"key":"1646_CR46","first-page":"M99","volume":"54","author":"K Friese","year":"1994","unstructured":"Friese K (1994) Diagnosis and treatment of congenital toxoplasmosis. Geburtshilfe Und Frauenheilkunde 54:M99\u2013M101","journal-title":"Geburtshilfe Und Frauenheilkunde"},{"key":"1646_CR47","first-page":"135","volume":"26","author":"RE Wenk","year":"1981","unstructured":"Wenk RE, Gebhardt FC, Bhagavan BS, Lustgarten JA, McCarthy EF (1981) Tetracycline-associated fatty liver of pregnancy, including possible pregnancy risk after chronic dermatologic use of tetracycline. J Reprod Med 26:135\u2013141","journal-title":"J Reprod Med"},{"key":"1646_CR48","first-page":"821","volume":"36","author":"PJ Whalley","year":"1970","unstructured":"Whalley PJ, Martin FG, Adams RH, Combes B (1970) Disposition of tetracycline by pregnant women with acute pyelonephritis. Obstet Gynecol 36:821\u2013826","journal-title":"Obstet Gynecol"},{"key":"1646_CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-2115(99)00112-8","volume":"88","author":"AE Czeizel","year":"2000","unstructured":"Czeizel AE, Rockenbauer M (2000) A population-based case\u2013control study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 88:27\u201333","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1646_CR50","first-page":"1244","volume":"36","author":"S Takayama","year":"1986","unstructured":"Takayama S, Watanabe T, Akiyama Y, Ohura K, Harada S, Matsuhashi K, Mochida K, Yamashita N (1986) Reproductive toxicity of ofloxacin. Arzneimittelforschung 36:1244\u20131248","journal-title":"Arzneimittelforschung"},{"key":"1646_CR51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/019262339202000319","volume":"20","author":"AW Gough","year":"1992","unstructured":"Gough AW, Kasali OB, Sigler RE, Baragi V (1992) Quinolone arthropathy acute toxicity to immature articular cartilage. Toxicol Pathol 20:436\u2013449","journal-title":"Toxicol Pathol"},{"key":"1646_CR52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0301-2115(95)02524-3","volume":"69","author":"C Schaefer","year":"1996","unstructured":"Schaefer C, Amoura-Elefant E, Vial T, Ornoy A, Garbis H, Robert E, Rodriguez-Pinilla E, Pexieder T, Prapas N, Merlob P (1996) Pregnancy outcome after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur J Obstet Gynecol Reprod Biol 69:83\u201389","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1646_CR53","first-page":"535","volume":"84","author":"M Berkovitch","year":"1994","unstructured":"Berkovitch M, Pastuszak A, Gazarian M, Lewis M, Koren G (1994) Safety of the new quinolones in pregnancy. Obstet Gynecol 84:535\u2013538","journal-title":"Obstet Gynecol"},{"key":"1646_CR54","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/AAC.42.6.1336","volume":"42","author":"R Loebstein","year":"1998","unstructured":"Loebstein R, Addis A, Ho E, Andreou R et al (1998) Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob Agents Chemother 42:1336\u20131339","journal-title":"Antimicrob Agents Chemother"},{"key":"1646_CR55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-3782(87)90039-9","volume":"15","author":"MR Holdiness","year":"1987","unstructured":"Holdiness MR (1987) Teratology of the antituberculosis drugs. Early Hum Dev 15:61\u201374","journal-title":"Early Hum Dev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1646-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1646-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1646-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T01:45:41Z","timestamp":1559526341000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1646-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,3]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1646-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,3]]}}}